Back to Journals » International Journal of General Medicine » Volume 16

Commentary and Critique to “Red Cell Distribution Width/Albumin Ratio: A Predictor of in-Hospital All-Cause Mortality in Patients with Acute Myocardial Infarction in the ICU” by Jian et al [Letter]

Authors Güven AT 

Received 20 March 2023

Accepted for publication 24 April 2023

Published 28 April 2023 Volume 2023:16 Pages 1589—1590

DOI https://doi.org/10.2147/IJGM.S413290

Checked for plagiarism Yes

Editor who approved publication: Dr Scott Fraser



Alper Tuna Güven

Başkent University Faculty of Medicine, Department of Internal Medicine, Division of General Internal Medicine, Ankara, Turkey

Correspondence: Alper Tuna Güven, Başkent University Faculty of Medicine, Department of Internal Medicine, Division of General Internal Medicine, Taşkent Caddesi (Eski 1. Cadde) 77. Sokak (Eski 16. Sokak) No: 11 06490 Bahçelievler, Ankara, Turkey, Email [email protected]


View the original paper by Dr Jian and colleagues


Dear editor

I have read with great enthusiasm the paper that Jian et al have submitted. While their findings regarding red cell distribution width-to-albumin ratio (RAR) and acute myocardial infarction (AMI) mortality are interesting and consistent with the existing literature, their manuscript contains a major epidemiological nomenclature flaw. Although the conclusion part of the main text is correct, the conclusion part of the abstract states that the RAR was an independent risk factor for in-hospital all-cause mortality in intensive care patients with AMI. A risk factor is a feature that has a “causal impact” on disease occurrence, progression, or severity, and the disease would not have occurred in its current form in the absence of the risk factor.1

As the authors have mentioned in the manuscript, red cell distribution width (RDW) and albumin levels alter during inflammatory states. While the former is a negative acute phase reactant, the latter is known to increase in both acute and chronic inflammatory states.2–4 Albeit their levels change during inflammation, they are not the cause of inflammation but only the surrogate markers of various inflammatory conditions. Specifically, lower albumin or higher RDW levels in a patient only reflect that patient having a higher level of inflammation compared to a patient with higher albumin or lower RDW levels. Studies on these indexes always conclude that “RAR is a predictor of” or “RAR is associated with”.3,4 Thus, the term “independent risk factor” is inappropriate in this context. I recommend authors make an erratum on the abstract.

Disclosure

The author reports no conflict of interest in this communication.

References

1. Dekkers OM, Vandenbroucke JP. Causaliteit: over risicofactoren en interventies [Causality: risk factors and interventions]. Ned Tijdschr Geneeskd. 2013;157(24):A5882.

2. Peng Y, Guan X, Wang J, Ma J. Red cell distribution width is correlated with all-cause mortality of patients in the coronary care unit. J Int Med Res. 2020;48(7):300060520941317. doi:10.1177/0300060520941317

3. Zhao N, Hu W, Wu Z, et al. The red blood cell distribution width-albumin ratio: a promising predictor of mortality in stroke patients. Int J Gen Med. 2021;14:3737–3747. doi:10.2147/IJGM.S322441

4. Xu W, Huo J, Chen G, et al. Association between red blood cell distribution width to albumin ratio and prognosis of patients with sepsis: a retrospective cohort study. Front Nutr. 2022;9:1019502. doi:10.3389/fnut.2022.1019502

Creative Commons License © 2023 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.